Attachment 2a - 60 day FRN

Federal Register / Vol. 72, No. 146 / Tuesday, July 31, 2007 / Notices
Dated: July 20, 2007.
David A. Schwartz,
Director, National Institute of Environmental
Health Sciences, and National Toxicology
Program.
[FR Doc. E7–14689 Filed 7–30–07; 8:45 am]
BILLING CODE 4140–01–P

Agency for Healthcare Research and
Quality

In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Announcement of
Availability of Funds for Grants
regarding Family Planning Services
Delivery Improvement (SDI) Research
are to be reviewed and discussed at this
meeting. This program is sponsored by
the Office of Populations Affairs. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.

rmajette on PROD1PC64 with NOTICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

Notice of Meeting

SEP Meeting on: Family Planning Services
Delivery Improvement (SDI) Research.
Date: August 23, 2007 (Open on August 23
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting).
Place: John M. Eisenberg Building, AHRQ
Conference Center, 540 Gaither Road,
Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, HARQ, 540 Gaither Road, Room

15:11 Jul 30, 2007

Dated: July 24, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–3706 Filed 7–30–07; 8:45 am]
BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

VerDate Aug<31>2005

2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.

Jkt 211001

[60Day–07–07BE]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Research to Reduce Time to
Treatment for Heart Attack/Myocardial
Infraction for Rural American Indians/
Alaska Natives (AI/AN)—NEW—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).

PO 00000

Frm 00056

Fmt 4703

Sfmt 4703

41757

Background and Brief Description
Every year, approximately 1.1 million
Americans have a first or recurrent heart
attack/myocardial infarction (MI) and
about one third of these will be fatal.
Early recognition of MI by both the
victim and bystanders followed by
prompt cardiac emergency and
advanced care has a direct effect on
patient outcomes (heart damage,
morbidity and mortality): the shorter the
delay to treatment, the better the
outcomes. Results of a recent Behavioral
Risk Factor Survey (BRFSS) survey
showed that public recognition of major
MI symptoms and the need for
immediate action by calling 9–1–1 was
poor and that there is a need for
increased public health efforts. Patient
delay accounts for most of the lag in
treatment.
Data from the National MI Registry
show that the greatest disparity for
delay in treatment exists among the
racial and ethnic groups of American
Indian/Alaskan Native group. The
NATIVE study shows that rural
American Indians presenting with acute
MI have marked delays in time to
treatment (12% of patients waited
between 12–24 hours and 23% waited
more than 24 hours to present) thus,
limiting treatment options; the primary
cause of the delay was due to patient
misunderstandings about the symptoms
of MI.
The project will contribute to our
understanding of AI/AN populations
and their perceptions of and
misconceptions about MI and the need
for immediate treatment. Information
gained from this project will provide the
details needed to tailor message(s) for
this population. The agency will
develop culturally-tailored messages for
native populations that will contribute
to the existing National Heart Attack
program (NHLBI) ‘‘Act in Time’’
messages.
There will be a minimum of 84 key
informant interviews and 16 persons in
the two focus groups. The key
informants will consist of healthcare
providers, community leader, and
persons who have had an MI. Key
informants will be identified for
interviews through a clustered,
multistate snowball sampling technique.
In recognition of the tribal diversity;
study participants will represent three
AI/AN regions of the U.S.: Great Plains
identified by the Aberdeen Area Indian
Health Service area, the South West
distinct to the Phoenix, Albuquerque
and Tucson areas and Alaskan Natives.
Interview participants will have
established relationships with tribes or

E:\FR\FM\31JYN1.SGM

31JYN1

41758

Federal Register / Vol. 72, No. 146 / Tuesday, July 31, 2007 / Notices

are members of tribes, and have a good
sense of cultural health beliefs.
The healthcare provider group will
consist of nomination by the Indian
Health Service Chief Medical Officer
(IHSCMO), who will nominate 3 MD/
NP’s or PA’s and 3 nurses in each
region. The participating emergency
care providers will each be asked to
nominate 2 providers from a cardiology
clinic (cardiologists or cardiac nurses)
and/or a pre-hospital (EMT/Paramedic)
provider. The 6 original from each
region will subtotal to 18 emergency
care providers plus the 2 individuals
they each nominate will subtotal to 36
from each region, a total of 54 prehospital and cardiology providers

participate in the key informant
interviews will equal a minimum of
approximately 27 health providers, 15
community members or 42 key
informant interview, each contacts 2
individuals, a minimum of 168
respondents to the survey.
After the key informant interviews
have been completed and analyzed
there will be two community focus
groups each comprised of 8 to 10
participants from all three regions held.
The first involving patients who have
had an MI and the second focus group
will involve community members at risk
for MIs.
There are no costs to the respondent
except their time to participate in the
survey.

(medical providers) key informant
interviews covering all three regions.
The community key informants will
consist of 3 tribal health directors who
will nominate 3 community key
informants from each region, who will
then each nominate 2 additional
community members to be interviewed
for a sample of 30 community key
informants.
The individual key informant
interviews of the group of patients who
have had an MI or have a high risk of
MI, nominated by the physicians, nurses
and community members will be asked
to nominate individuals whom they
know have had or are at risk for a heart
attack. The medical providers and
community members asked to

ESTIMATED ANNUALIZED BURDEN HOURS
Respondents

Number of
respondents

No. of
responses per
respondent

Average
burden per
response (in
hrs.)

Healthcare providers ........................................................................................
Community leaders ..........................................................................................
Community members interviews ......................................................................
(2) Community member focus group retreats .................................................
Total ..........................................................................................................

54
30
168
20
........................

1
1
1
1
........................

1
1
1
8
........................

Dated: July 25, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–14703 Filed 7–30–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–07–06BN]

rmajette on PROD1PC64 with NOTICES

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to:
omb@cdc.gov.

VerDate Aug<31>2005

15:11 Jul 30, 2007

Jkt 211001

Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Conduct a Chronic Fatigue Syndrome
Registry Pilot Test (Bibb County,
Georgia)—New—National Center for
Infectious Diseases (NCID) Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is tasked with establishing a
registry of chronic fatigue syndrome
(CFS) and other fatiguing illnesses. The
objective of the registry is to identify
persons with unexplained fatiguing
illnesses, including CFS, who access the
healthcare system because of their
symptoms. Patients will be between the
ages of 12 and 59, inclusive.

PO 00000

Frm 00057

Fmt 4703

Sfmt 4703

Total burden
(in hours)
54
30
168
160
412

Specific aims of the registry are; (1)
Identify and enroll patients with CFS
and other unexplained fatiguing
illnesses who are receiving medical and
ancillary medical care and describe
their epidemiologic and clinical
characteristics; (2) follow CFS patients
and patients with other fatiguing
illnesses over time to characterize the
natural history of CFS and other
unexplained fatiguing illnesses; (3)
assess and monitor health care
providers’ knowledge, attitudes, and
beliefs concerning CFS; (4) and to
identify well-characterized CFS patients
for clinical studies and intervention
trials. These specific aims require
inclusion of subjects in early stages of
CFS (i.e., ill less than one year duration)
who can be followed longitudinally to
assess changes in their CFS symptoms.
Data on persons with CFS in the general
population has been collected in a
separate study and is not an objective of
this Registry.
In order to determine the most
effective and cost-efficient design for
achieving the objective and specific
aims, CDC will conduct a pilot test of
the Registry of CFS and other fatiguing
illnesses in Bibb County, Georgia. The
CFS Registry Pilot Test will assess two
Registry designs for efficacy and
efficiency in identifying adult and
adolescent subjects with CFS who are

E:\FR\FM\31JYN1.SGM

31JYN1